Aussie Biota Merges With Nabi Of U.S. To Gain Nasdaq Exchange Listing
This article was originally published in PharmAsia News
Executive Summary
Australia’s Biota Holdings said it would merge with Nabi Biopharmaceuticals of the U.S. so it can switch its stock market listing from Australia to the Nasdaq Stock Exchange.